Full text is available at the source.
Improving Nme2Cas9 and Nme2SmuCas9 Gene Editing Proteins and Base Editors
Updated
Abstract
Adenine and cytosine base editors could correct approximately 30% of human pathogenic variants.
- Base editors enable precise conversions of A:T-to-G:C and C:G-to-T:A base pairs.
- Therapeutic use of base editors is limited by factors such as PAM availability and accuracy.
- Nme2Cas9 and its derivatives have been developed to enhance editing near NCC PAMs.
- Engineering efforts have yielded base editors with improved activity and vector compatibility.
- Editing and specificity profiles of the enhanced variants were defined using paired guide-target libraries.
Simplified